Envestnet Asset Management’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.17M Sell
18,315
-121
-0.7% -$7.76K ﹤0.01% 3180
2025
Q1
$1.17M Sell
18,436
-1,258
-6% -$79.8K ﹤0.01% 3100
2024
Q4
$1.31M Sell
19,694
-1,256
-6% -$83.6K ﹤0.01% 2979
2024
Q3
$1.46M Sell
20,950
-3,497
-14% -$244K ﹤0.01% 2877
2024
Q2
$1.58M Buy
24,447
+909
+4% +$58.9K ﹤0.01% 2739
2024
Q1
$1.52M Buy
23,538
+6,084
+35% +$394K ﹤0.01% 2752
2023
Q4
$1.15M Buy
17,454
+2,124
+14% +$140K ﹤0.01% 2840
2023
Q3
$874K Buy
15,330
+651
+4% +$37.1K ﹤0.01% 2904
2023
Q2
$900K Buy
14,679
+3,733
+34% +$229K ﹤0.01% 2826
2023
Q1
$687K Buy
10,946
+2,518
+30% +$158K ﹤0.01% 2937
2022
Q4
$535K Sell
8,428
-2,145
-20% -$136K ﹤0.01% 3059
2022
Q3
$623K Buy
+10,573
New +$623K ﹤0.01% 2880
2022
Q1
Sell
-3,354
Closed -$239K 4025
2021
Q4
$239K Buy
+3,354
New +$239K ﹤0.01% 3555
2019
Q2
Sell
-5,095
Closed -$281K 3064
2019
Q1
$281K Buy
+5,095
New +$281K ﹤0.01% 2627
2018
Q3
Sell
-2,836
Closed -$155K 2199
2018
Q2
$155K Hold
2,836
﹤0.01% 1794
2018
Q1
$139K Buy
2,836
+143
+5% +$7.01K ﹤0.01% 1790
2017
Q4
$127K Buy
2,693
+72
+3% +$3.4K ﹤0.01% 2022
2017
Q3
$131K Sell
2,621
-987
-27% -$49.3K ﹤0.01% 1989
2017
Q2
$165K Buy
3,608
+1,091
+43% +$49.9K ﹤0.01% 1939
2017
Q1
$106K Hold
2,517
﹤0.01% 2166
2016
Q4
$98K Buy
2,517
+635
+34% +$24.7K ﹤0.01% 2188
2016
Q3
$79K Sell
1,882
-2,955
-61% -$124K ﹤0.01% 2426
2016
Q2
$179K Buy
4,837
+103
+2% +$3.81K ﹤0.01% 2156
2016
Q1
$181K Sell
4,734
-13,594
-74% -$520K ﹤0.01% 2122
2015
Q4
$926K Sell
18,328
-188
-1% -$9.5K ﹤0.01% 1326
2015
Q3
$847K Buy
18,516
+3,019
+19% +$138K ﹤0.01% 1368
2015
Q2
$904K Sell
15,497
-242
-2% -$14.1K ﹤0.01% 1443
2015
Q1
$868K Buy
15,739
+419
+3% +$23.1K ﹤0.01% 1348
2014
Q4
$769K Sell
15,320
-528
-3% -$26.5K 0.01% 593
2014
Q3
$733K Sell
15,848
-2,816
-15% -$130K 0.01% 670
2014
Q2
$816K Sell
18,664
-3,578
-16% -$156K 0.01% 618
2014
Q1
$926K Buy
22,242
+665
+3% +$27.7K 0.01% 484
2013
Q4
$799K Buy
21,577
+930
+5% +$34.4K 0.01% 502
2013
Q3
$724K Buy
20,647
+12,842
+165% +$450K 0.01% 510
2013
Q2
$225K Buy
+7,805
New +$225K ﹤0.01% 778